Search for Clinical Trial Results
Carcinoma, Pancreatic Ductal - 27 Studies Found
Status | Study |
Active, not recruiting |
Study Name: Phase II Study of MEDI4736 Monotherapy or in Combinations With Tremelimumab in Metastatic Pancreatic Ductal Carcinoma Condition: Metastatic Pancreatic Ductal Adenocarcinoma Date: 2015-08-27 Interventions:
|
Completed |
Study Name: Pilot Phase 2 Study to Investigate the Preliminary Efficacy and Safety of INNO-206 in Advanced Pancreatic Cancer Condition: Pancreatic Ductal Adenocarcinoma Date: 2012-04-13 Interventions: Drug: INNO-206 INNO-206 at a total dose of 350 mg/m2 (260 mg/m2 doxorubicin equivalent) will be administ |
Completed |
Study Name: A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumors Condition:
|
Enrolling by invitation |
Study Name: Clinical Trial of Pancreatic Cancer in Stockholm. Condition: Pancreatic Cancer Date: 2014-06-11 Interventions: Procedure: Pancreatic Surgery Surgical removal of the pancreatic tumour (cancer) in the intervention gro |
Active, not recruiting |
Study Name: PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Subjects With Stage IV Untreated Pancreatic Cancer Condition: Metastatic Pancreatic Cancer Date: 2013-04-22 Interventions:
|